company background image
VHT

Volpara Health TechnologiesASX:VHT Stock Report

Market Cap

AU$310.4m

7D

-0.4%

1Y

-17.1%

Updated

18 Oct, 2021

Data

Company Financials +
VHT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health5/6
Dividends0/6

VHT Overview

Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide.

Rewards

Earnings are forecast to grow 78.23% per year

Earnings have grown 8.4% per year over the past 5 years

Risk Analysis

No risks detected for VHT from our risk checks.

Price History & Performance

Summary of all time highs, changes and price drops for Volpara Health Technologies
Historical stock prices
Current Share PriceAU$1.24
52 Week HighAU$1.05
52 Week LowAU$1.72
Beta0.52
1 Month Change-0.80%
3 Month Change8.77%
1 Year Change-17.06%
3 Year Change-5.70%
5 Year Change72.22%
Change since IPO148.00%

Recent News & Updates

Jun 03
Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)

Calculating The Intrinsic Value Of Volpara Health Technologies Limited (ASX:VHT)

In this article we are going to estimate the intrinsic value of Volpara Health Technologies Limited ( ASX:VHT ) by...

Shareholder Returns

VHTAU Healthcare ServicesAU Market
7D-0.4%0.2%0.9%
1Y-17.1%46.7%20.2%

Return vs Industry: VHT underperformed the Australian Healthcare Services industry which returned 46.7% over the past year.

Return vs Market: VHT underperformed the Australian Market which returned 20.2% over the past year.

Price Volatility

Is VHT's price volatile compared to industry and market?
VHT volatility
VHT Beta0.52
Industry Beta0.49
Market Beta1

Stable Share Price: VHT is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: VHT's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2009175Ralph Highnamhttps://volparasolutions.com

Volpara Health Technologies Limited provides breast imaging analytics and analysis products for the early detection of breast cancer in the medical device and practice management software industry worldwide. The company offers Volpara Analytics software, a cloud-based breast imaging analytics platform that delivers performance monitoring solutions; Volpara Live, which provides radiographers instant patient-based image quality feedback; Volpara Lung, a patient management software; and Volpara Patient Hub, a customizable mammography reporting and patient communications software. It also offers Volpara Risk, an integration with Patient Hub that uses Tyrer-Cuzick v8 Risk Evaluation Tool to calculate patients’ risk of developing breast cancer; Volpara Scorecard, which displays patient breast density and risk insights essential for improved clinical decision-making and early detection; and Volpara Science, an AI-based software that powers Volpara software products.

Volpara Health Technologies Fundamentals Summary

How do Volpara Health Technologies's earnings and revenue compare to its market cap?
VHT fundamental statistics
Market CapNZ$325.65m
Earnings (TTM)-NZ$17.49m
Revenue (TTM)NZ$19.75m

16.6x

P/S Ratio

-18.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
VHT income statement (TTM)
RevenueNZ$19.75m
Cost of RevenueNZ$1.69m
Gross ProfitNZ$18.06m
ExpensesNZ$35.54m
Earnings-NZ$17.49m

Last Reported Earnings

Mar 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.07
Gross Margin91.43%
Net Profit Margin-88.56%
Debt/Equity Ratio3.4%

How did VHT perform over the long term?

See historical performance and comparison

Valuation

Is Volpara Health Technologies undervalued compared to its fair value and its price relative to the market?

4.49x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: VHT (A$1.24) is trading above our estimate of fair value (A$0.03)

Significantly Below Fair Value: VHT is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: VHT is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: VHT is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate VHT's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: VHT is overvalued based on its PB Ratio (4.5x) compared to the AU Healthcare Services industry average (3.8x).


Future Growth

How is Volpara Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

78.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VHT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.9%).

Earnings vs Market: VHT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: VHT's is expected to become profitable in the next 3 years.

Revenue vs Market: VHT's revenue (30.8% per year) is forecast to grow faster than the Australian market (5.5% per year).

High Growth Revenue: VHT's revenue (30.8% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: VHT's Return on Equity is forecast to be low in 3 years time (7.6%).


Past Performance

How has Volpara Health Technologies performed over the past 5 years?

8.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VHT is currently unprofitable.

Growing Profit Margin: VHT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: VHT is unprofitable, but has reduced losses over the past 5 years at a rate of 8.4% per year.

Accelerating Growth: Unable to compare VHT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: VHT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).


Return on Equity

High ROE: VHT has a negative Return on Equity (-24.02%), as it is currently unprofitable.


Financial Health

How is Volpara Health Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: VHT's short term assets (NZ$42.9M) exceed its short term liabilities (NZ$17.8M).

Long Term Liabilities: VHT's short term assets (NZ$42.9M) exceed its long term liabilities (NZ$4.0M).


Debt to Equity History and Analysis

Debt Level: VHT's debt to equity ratio (3.4%) is considered satisfactory.

Reducing Debt: VHT had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: VHT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if VHT has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Volpara Health Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VHT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VHT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VHT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VHT's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VHT's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.8yrs

Average management tenure


CEO

Ralph Highnam

no data

Tenure

NZ$543,639

Compensation

Dr. Ralph Highnam, BSc (Hons) 1st Class, MSc, PhD, serves as the Group Chief Executive Officer and Managing Director at Volpara Health Technologies Limited . He is the Founder of Volpara Health Technologie...


CEO Compensation Analysis

Compensation vs Market: Ralph's total compensation ($USD384.63K) is below average for companies of similar size in the Australian market ($USD556.28K).

Compensation vs Earnings: Ralph's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: VHT's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

Experienced Board: VHT's board of directors are considered experienced (6.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Volpara Health Technologies Limited's employee growth, exchange listings and data sources


Key Information

  • Name: Volpara Health Technologies Limited
  • Ticker: VHT
  • Exchange: ASX
  • Founded: 2009
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: AU$310.421m
  • Shares outstanding: 251.35m
  • Website: https://volparasolutions.com

Number of Employees


Location

  • Volpara Health Technologies Limited
  • Simpl House
  • Level 14
  • Wellington
  • 6011
  • New Zealand

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/18 07:05
End of Day Share Price2021/10/18 00:00
Earnings2021/03/31
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.